Peripheral Vascular Chronic Total Occlusion Devices Market Size is predicted to witness at a 4.84 % CAGR during the forecast period for 2024-2031.
Chronic Total Occlusion (CTO) devices are medical devices intended to treat peripheral vascular disease caused by complete blood artery blockage (chronic total occlusion). Because of the complexity of the occlusion, these devices are often used when standard angioplasty and stent implantation are not feasible. The rising frequency of cardiac problems such as peripheral vascular diseases and heart failure, increased investments and financing for developing such systems, and rapid improvements in peripheral vascular chronic complete occlusion devices can all be linked to the market's consistent revenue growth. Several innovative technologies have been created in recent years to advance the success rates of CTO endovascular intervention. These developments are assisting the market's revenue growth.
However, the pandemic impacted worldwide supply chains, resulting in shortages of various medical devices, particularly CTO devices. Manufacturers encountered difficulties procuring raw materials and components, which could have hampered manufacturing and delivery.
The Peripheral Vascular Chronic Total Occlusion Devices Market is segmented on the basis of product and end-use. As per product type, the market is segmented as crossing CTO devices, extraluminal devices, balloon catheters, guidewires, and stents. The end-user segment includes hospitals, cardiac centres, and ambulatory surgical centres.
The crossing CTO devices category is expected to hold a major share of the global Peripheral Vascular Chronic Total Occlusion Devices Market in 2022. CTO crossover devices provide interventionists with another option for addressing problematic lower extremity peripheral artery occlusions. These devices can boost crossing rates, delivering therapeutic devices to the target lesion. Adopting modern CTO crossing devices provides a more constant distal entrance and a shorter crossing time. The present devices are designed to allow regulated subintimal tracking and entry into the distal true lumen or remain in the true lumen. The first step in employing advanced crossing methods is to improve fundamental knowledge of wire qualities such as penetrability, pushability, trackability, bending, and lubricity. These are some of the primary variables driving revenue growth in this industry.
The catheters segment is estimated to grow at a rapid rate in the global Peripheral Vascular Chronic Total Occlusion Devices Market. Longer sheaths, large-bore guiding catheters, guide catheter extensions, and anchor procedures should be used to improve the success rate and effectiveness of CTO PCI. Crossing catheters with unique designs have been developed to improve CTO crossing rates by allowing proximal cap penetration to introduce endovascular devices to the target lesion. Using a microcatheter or over-the-wire balloon in CTO PCI is strongly recommended since it boosts guidewire penetration power and enables tip and guidewire changes. Vascular doctors can now bridge CTOs using specially developed catheters. These technologies include microdissection, laser, vibrational energy, and intravascular ultrasound imaging. These are some of the primary variables driving revenue growth.
The North America Peripheral Vascular Chronic Total Occlusion Devices Market is expected to record the topmost market share of revenue in the near future. The peripheral vascular chronic total occlusion devices market is expanding in this region, owing to the increasing expansion of cardiac centres in the field of paediatrics perfusion, as well as rising product launches by major market companies developing peripheral vascular chronic total occlusion devices and increasing regulatory approvals, particularly in the United States, which has resulted in the market's continued revenue growth. Many Asia Pacific countries have had strong economic growth, which has resulted in greater healthcare spending and improved healthcare infrastructure. This advancement encourages the use of modern medical technology, such as peripheral vascular chronic complete occlusion devices.
|
Report Attribute |
Specifications |
|
Growth Rate CAGR |
CAGR of 4.84% from 2023 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Million and CAGR from 2023 to 2031 |
|
Historic Year |
2019 to 2022 |
|
Forecast Year |
2023-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Product Type, End-User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
Medtronic, Abbott., Boston Scientific Corporation, Bard Peripheral Vascular, Inc., Terumo Medical Corporation, Cordis, Avinger., BECTON, DICKINSON AND COMPANY., Reflow Medical, Inc., and Cook Medical. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Peripheral Vascular Chronic Total Occlusion Devices Market Snapshot
Chapter 4. Global Peripheral Vascular Chronic Total Occlusion Devices Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. COVID-19 Impact Analysis
Chapter 5. Market Segmentation 1: By Product Type Estimates & Trend Analysis
5.1. By Product Type & Market Share, 2019-2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By Product Type:
5.2.1. Crossing CTO Devices
5.2.2. Extraluminal Devices
5.2.3. Balloon Catheters
5.2.4. Guidewires
5.2.5. Stents
5.2.6. Others
Chapter 6. Market Segmentation 2: By End User Estimates & Trend Analysis
6.1. By Product Type & Market Share, 2019-2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2031 for the following By End User:
6.2.1. Hospitals
6.2.2. Cardiac Centers
6.2.3. Ambulatory Surgical Centers
Chapter 7. Peripheral Vascular Chronic Total Occlusion Devices Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) estimates and forecasts By Product Type, 2023-2031
7.1.2. North America Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) estimates and forecasts By End User, 2023-2031
7.1.3. North America Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) estimates and forecasts by country, 2023-2031
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) By Product Type, 2023-2031
7.2.2. Europe Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) By End User, 2023-2031
7.2.3. Europe Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) by country, 2023-2031
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.4. Spain
7.2.4.1. UK
7.2.4.2. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) By Product Type, 2023-2031
7.3.2. Asia Pacific Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) By End User, 2023-2031
7.3.3. Asia Pacific Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) by country, 2023-2031
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) By Product Type, 2023-2031
7.4.2. Latin America Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) By End User, 2023-2031
7.4.3. Latin America Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) by country, (US$ Million) 2023-2031
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. Middle East & Africa
7.5.1. Middle East & Africa Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) By Product Type, (US$ Million)
7.5.2. Middle East & Africa Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) By End User, (US$ Million)
7.5.3. Middle East & Africa Peripheral Vascular Chronic Total Occlusion Devices Market revenue (US$ Million) by country, (US$ Million) 2023-2031
7.5.3.1. South Africa
7.5.3.2. GCC Countries
7.5.3.3. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Medtronic
8.2.2. Boston Scientific Corporation
8.2.3. Bard Peripheral Vascular, Inc.
8.2.4. Terumo Medical Corporation
8.2.5. Cordis
8.2.6. BECTON, DICKINSON AND COMPANY
8.2.7. Reflow Medical, Inc.
8.2.8. Cook Medical
Peripheral Vascular Chronic Total Occlusion Devices Market By Product-
Peripheral Vascular Chronic Total Occlusion Devices Market By End-Use-
Peripheral Vascular Chronic Total Occlusion Devices Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
